ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2210

The Canada-Denmark Fat Spondyloarthritis Spine Score: Validation of a New Scoring Method for the Evaluation of Fat Lesions in the Spine of Patients with Axial Spondyloarthritis

Susanne Juhl Pedersen1, Zheng Zhao2, Robert GW Lambert3, Mikkel Østergaard4, Ulrich Weber5 and Walter P. Maksymowych6, 1Dept. of Rheumatology, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 2Department of Rheumatology, University of Alberta and PLA General Hospital, Beijing, PR China, Beijing, AB, China, 3Radiology, University of Alberta, Edmonton, AB, Canada, 4Department of Rheumatology, Glostrup Hospital, Copenhagen, Denmark, 5Rheumatology, Balgrist University Hospital, Zurich, Switzerland, 6Department of Medicine, University of Alberta, Edmonton, AB, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Magnetic resonance imaging (MRI) and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose: Fat metaplasia has been shown to follow resolution of inflammation in axial SpA and this may be evident within one year (1). Fat metaplasia at vertebral corners has also been shown to predict the development of new syndesmophytes (2). Consequently, the scoring of fat lesions in the spine may constitute both an important measure of treatment efficacy as well as a responsive surrogate for new bone formation. Because of this, we developed and validated a new scoring system for fat lesions in the spine, the CanDen Fat SpA Spine Score (FASSS), which addresses the localization and phenotypic diversity of fat lesions in SpA.

Methods: In 2007, the Canada-Denmark MRI working group developed anatomy-based definitions of fat lesions on T1 weighted sagittal MRI scans of the spine (3). In 2011, further definitions, a reference image module, and an online spinal unit schematic for data entry were developed, which formed the basis for a scoring method. The method comprises six different types of fat lesions defined according to their anatomical location, which are recorded dichotomously (present/absent) at each vertebral endplate from C2 lower to S1 upper (scoring range per disco-vertebral unit in C spine: 0-8, and in T and L spine: 0-18). Two rheumatologists assessed spine MRI scans obtained at two time points (mean 1.5 years (SD 0.5)) in chronological order of 66 patients with axial SpA (exercise 1). Scoring methodology and reference image set were revised based on discrepant cases in exercise 1. Then the two readers re-read 30 randomly selected pairs of MRI scans from the first exercise together with 40 new pairs of MRI scans (exercise 2) (mean 1.7 years (SD: 0.8)) (exercise 2).  Inter-observer reliability were assessed by intra-class correlation coefficients (ICCs), and responsiveness as mean change per year by standardized response mean (SRM).

Results: In exercise 2, the change in fat scores ranged from -34 to 52 for reader A and from -38 to 61 for reader B. Inter-observer ICC scores were high to very high for the FASSS baseline scores, and improved substantially in change scores from exercise 1 to 2 (Table). This was particularly notable for the 30 patients evaluated in both exercises. Inter-observer ICCs for baseline scores were high for all spinal segments, and change scores improved from small to moderate (C spine), and from moderate to high (L spine) and very high (T spine). For total FASSS score the mean change/year and SRM were 2.4 and 0.34 for reader A and 3.7 and 0.26 for reader B.

Conclusion: The FASSS meets essential validation criteria for further assessment in axial SpA, and may thus be useful for follow-up of SpA in clinical trials and practice.

References: 1. Chiowchanwisawakit et al. ARD 2010; 2. Chiowchanwisawakit et al. AR 2011; 3. Østergaard et al. J Rheum 2009

Table

Interobserver ICCs for spinal segments scored according to the CanDen Fat SpA Spine Score (FASSS)

Inter-observer ICCs (CI95%)

Exercise 1

(n=65)

Exercise 2

(n=70)

Exercise 1 (n=30)*

Exercise 2

(n=30)*

Baseline ICC

(95% CI)

Change ICC

(95% CI)

Baseline ICC

(95% CI)

Change ICC

(95% CI)

Change ICC

(95% CI)

Change ICC

(95% CI)

C spine

0.76 (0.62;0.85)

0.38 (0.16;0.57)

0.82 (0.72;0.88)

0.49 (0.29;0.65)

0.27 (-0.05;0.56)

0.54 (0.23;0.75)

T spine

0.89 (0.78;0.94)

0.55 (0.32;0.71)

0.88 (0.64;0.95)

0.94 (0.87;0.97)

0.42 (0.08;0.67)

0.70 (0.46;0.85)

L spine

0.77 (0.60;0.87)

0.45 (0.22;0.63)

0.92 (0.88;0.94)

0.74 (0.64;0.82)

0.48 (0.15;0.71)

0.75 (0.48;0.88)

FASSS

0.89 (0.78;0.93)

0.53 (0.21;0.71)

0.95 (0.91;0.97)

0.84 (0.75;0.90)

0.41 (0.02;0.68)

0.64 (0.37;0.81)

*The 30 patients, that were scored two times, were a subgroup of patients in exercise 1 and 2.


Disclosure:

S. J. Pedersen,
None;

Z. Zhao,
None;

R. G. Lambert,
None;

M. Østergaard,
None;

U. Weber,
None;

W. P. Maksymowych,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-canada-denmark-fat-spondyloarthritis-spine-score-validation-of-a-new-scoring-method-for-the-evaluation-of-fat-lesions-in-the-spine-of-patients-with-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology